ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 185065 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 185065; 2) Community: the network communities that were significantly associated with the response to NSC 185065; 3) Molecule: the relationships between components within communities and NSC 185065; 4) MDR: the compounds that were significantly associated with the NSC 185065.

NSC Compound Enrichment Correlation
NSC 693626 Null 0.00824865245912294 0.40564179
NSC 699766 Benzoic acid, 2-(2,2-diphenylcyclopentyloxy)ethenyl ester, (racemic)- 0.00824865245912294 0.40478945
NSC 709483 Null 0.00824865245912294 0.13540912
NSC 71669 Null 0.00824865245912294 0.0085284118
NSC 716951 Null 0.00824865245912294 0.16970575
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.00824865245912294 0.20588699
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00824865245912294 0.095770387
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.00824865245912294 0.29816004
NSC 740 Methotrexate 0.00824865245912294 0.17116256
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.00824865245912294 0.067999393
Total:106  Current:29    [First] [Prev] [Next] [Last]